EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma

Nicole McKinney, Liangping Yuan, Hongying Zhang, Jingbo Liu, Yoon-Jae Cho, Elisabeth Rushing, Matthew Schniederjan, Tobey J. MacDonald

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Eph receptors and ephrin ligands are master regulators of oncogenic signaling required for proliferation, migration, and metastasis. Yet, Eph/ephrin expression and activity in medulloblastoma (MB), the most common malignant brain tumor of childhood, remains poorly defined. We hypothesized that Eph/ephrins are differentially expressed by sonic hedgehog (SHH) and non-SHH MB and that specific members contribute to the aggressive phenotype. Affymetrix gene expression profiling of 29 childhood MB, separated into SHH (N = 11) and non-SHH (N = 18), was performed followed by protein validation of selected Eph/ephrins in another 60 MB and two MB cell lines (DAOY, D556). Functional assays were performed using MB cells overexpressing or deleted for selected ephrins. We found EPHB4 and EFNA4 almost exclusively expressed by SHH MB, whereas EPHA2, EPHA8, EFNA1 and EFNA3 are predominantly expressed by non-SHH MB. The remaining family members, except EFNB1, are ubiquitously expressed by over 70–90 % MB, irrespective of subgroup. EFNB1 is the only member differentially expressed by 28 % of SHH and non-SHH MB. Corresponding protein expression for EphB/ephrinB1 and B2 was validated in MB. Only ephrinB2 was also detected in fetal cerebellum, indicating that EphB/ephrinB1 expression is MB-specific. EphrinB1 immunopositivity localizes to tumor cells within MB with the highest proliferative index. EphrinB1 overexpression promotes EphB activation, alters F-actin distribution and morphology, decreases adhesion, and significantly promotes proliferation. Either silencing or overexpression of ephrinB1 impairs migration. These results indicate that EphrinB1 is uniquely dysregulated in MB and promotes oncogenic responses in MB cells, implicating ephrinB1 as a potential target.

Original languageEnglish (US)
Pages (from-to)109-118
Number of pages10
JournalJournal of Neuro-Oncology
Volume121
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Medulloblastoma
Ephrins
Gene Expression Profiling
Brain Neoplasms
Cerebellum
Actins

Keywords

  • Dysregulation
  • EphrinB1
  • Medulloblastoma
  • Oncogenic signaling

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma. / McKinney, Nicole; Yuan, Liangping; Zhang, Hongying; Liu, Jingbo; Cho, Yoon-Jae; Rushing, Elisabeth; Schniederjan, Matthew; MacDonald, Tobey J.

In: Journal of Neuro-Oncology, Vol. 121, No. 1, 01.01.2015, p. 109-118.

Research output: Contribution to journalArticle

McKinney, N, Yuan, L, Zhang, H, Liu, J, Cho, Y-J, Rushing, E, Schniederjan, M & MacDonald, TJ 2015, 'EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma', Journal of Neuro-Oncology, vol. 121, no. 1, pp. 109-118. https://doi.org/10.1007/s11060-014-1618-8
McKinney, Nicole ; Yuan, Liangping ; Zhang, Hongying ; Liu, Jingbo ; Cho, Yoon-Jae ; Rushing, Elisabeth ; Schniederjan, Matthew ; MacDonald, Tobey J. / EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma. In: Journal of Neuro-Oncology. 2015 ; Vol. 121, No. 1. pp. 109-118.
@article{0011528f15324deeab1944c724a9fbb2,
title = "EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma",
abstract = "Eph receptors and ephrin ligands are master regulators of oncogenic signaling required for proliferation, migration, and metastasis. Yet, Eph/ephrin expression and activity in medulloblastoma (MB), the most common malignant brain tumor of childhood, remains poorly defined. We hypothesized that Eph/ephrins are differentially expressed by sonic hedgehog (SHH) and non-SHH MB and that specific members contribute to the aggressive phenotype. Affymetrix gene expression profiling of 29 childhood MB, separated into SHH (N = 11) and non-SHH (N = 18), was performed followed by protein validation of selected Eph/ephrins in another 60 MB and two MB cell lines (DAOY, D556). Functional assays were performed using MB cells overexpressing or deleted for selected ephrins. We found EPHB4 and EFNA4 almost exclusively expressed by SHH MB, whereas EPHA2, EPHA8, EFNA1 and EFNA3 are predominantly expressed by non-SHH MB. The remaining family members, except EFNB1, are ubiquitously expressed by over 70–90 {\%} MB, irrespective of subgroup. EFNB1 is the only member differentially expressed by 28 {\%} of SHH and non-SHH MB. Corresponding protein expression for EphB/ephrinB1 and B2 was validated in MB. Only ephrinB2 was also detected in fetal cerebellum, indicating that EphB/ephrinB1 expression is MB-specific. EphrinB1 immunopositivity localizes to tumor cells within MB with the highest proliferative index. EphrinB1 overexpression promotes EphB activation, alters F-actin distribution and morphology, decreases adhesion, and significantly promotes proliferation. Either silencing or overexpression of ephrinB1 impairs migration. These results indicate that EphrinB1 is uniquely dysregulated in MB and promotes oncogenic responses in MB cells, implicating ephrinB1 as a potential target.",
keywords = "Dysregulation, EphrinB1, Medulloblastoma, Oncogenic signaling",
author = "Nicole McKinney and Liangping Yuan and Hongying Zhang and Jingbo Liu and Yoon-Jae Cho and Elisabeth Rushing and Matthew Schniederjan and MacDonald, {Tobey J.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/s11060-014-1618-8",
language = "English (US)",
volume = "121",
pages = "109--118",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma

AU - McKinney, Nicole

AU - Yuan, Liangping

AU - Zhang, Hongying

AU - Liu, Jingbo

AU - Cho, Yoon-Jae

AU - Rushing, Elisabeth

AU - Schniederjan, Matthew

AU - MacDonald, Tobey J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Eph receptors and ephrin ligands are master regulators of oncogenic signaling required for proliferation, migration, and metastasis. Yet, Eph/ephrin expression and activity in medulloblastoma (MB), the most common malignant brain tumor of childhood, remains poorly defined. We hypothesized that Eph/ephrins are differentially expressed by sonic hedgehog (SHH) and non-SHH MB and that specific members contribute to the aggressive phenotype. Affymetrix gene expression profiling of 29 childhood MB, separated into SHH (N = 11) and non-SHH (N = 18), was performed followed by protein validation of selected Eph/ephrins in another 60 MB and two MB cell lines (DAOY, D556). Functional assays were performed using MB cells overexpressing or deleted for selected ephrins. We found EPHB4 and EFNA4 almost exclusively expressed by SHH MB, whereas EPHA2, EPHA8, EFNA1 and EFNA3 are predominantly expressed by non-SHH MB. The remaining family members, except EFNB1, are ubiquitously expressed by over 70–90 % MB, irrespective of subgroup. EFNB1 is the only member differentially expressed by 28 % of SHH and non-SHH MB. Corresponding protein expression for EphB/ephrinB1 and B2 was validated in MB. Only ephrinB2 was also detected in fetal cerebellum, indicating that EphB/ephrinB1 expression is MB-specific. EphrinB1 immunopositivity localizes to tumor cells within MB with the highest proliferative index. EphrinB1 overexpression promotes EphB activation, alters F-actin distribution and morphology, decreases adhesion, and significantly promotes proliferation. Either silencing or overexpression of ephrinB1 impairs migration. These results indicate that EphrinB1 is uniquely dysregulated in MB and promotes oncogenic responses in MB cells, implicating ephrinB1 as a potential target.

AB - Eph receptors and ephrin ligands are master regulators of oncogenic signaling required for proliferation, migration, and metastasis. Yet, Eph/ephrin expression and activity in medulloblastoma (MB), the most common malignant brain tumor of childhood, remains poorly defined. We hypothesized that Eph/ephrins are differentially expressed by sonic hedgehog (SHH) and non-SHH MB and that specific members contribute to the aggressive phenotype. Affymetrix gene expression profiling of 29 childhood MB, separated into SHH (N = 11) and non-SHH (N = 18), was performed followed by protein validation of selected Eph/ephrins in another 60 MB and two MB cell lines (DAOY, D556). Functional assays were performed using MB cells overexpressing or deleted for selected ephrins. We found EPHB4 and EFNA4 almost exclusively expressed by SHH MB, whereas EPHA2, EPHA8, EFNA1 and EFNA3 are predominantly expressed by non-SHH MB. The remaining family members, except EFNB1, are ubiquitously expressed by over 70–90 % MB, irrespective of subgroup. EFNB1 is the only member differentially expressed by 28 % of SHH and non-SHH MB. Corresponding protein expression for EphB/ephrinB1 and B2 was validated in MB. Only ephrinB2 was also detected in fetal cerebellum, indicating that EphB/ephrinB1 expression is MB-specific. EphrinB1 immunopositivity localizes to tumor cells within MB with the highest proliferative index. EphrinB1 overexpression promotes EphB activation, alters F-actin distribution and morphology, decreases adhesion, and significantly promotes proliferation. Either silencing or overexpression of ephrinB1 impairs migration. These results indicate that EphrinB1 is uniquely dysregulated in MB and promotes oncogenic responses in MB cells, implicating ephrinB1 as a potential target.

KW - Dysregulation

KW - EphrinB1

KW - Medulloblastoma

KW - Oncogenic signaling

UR - http://www.scopus.com/inward/record.url?scp=84921937277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921937277&partnerID=8YFLogxK

U2 - 10.1007/s11060-014-1618-8

DO - 10.1007/s11060-014-1618-8

M3 - Article

C2 - 25258252

AN - SCOPUS:84921937277

VL - 121

SP - 109

EP - 118

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -